Intradermal Delivery of Dendritic Cell-Targeting Chimeric mAbs Genetically Fused to Type 2 Dengue Virus Nonstructural Protein 1
Targeting dendritic cells (DCs) by means of monoclonal antibodies (mAbs) capable of binding their surface receptors (DEC205 and DCIR2) has previously been shown to enhance the immunogenicity of genetically fused antigens. This approach has been repeatedly demonstrated to enhance the induced immune r...
Main Authors: | Lennon Ramos Pereira, Elaine Cristina Matos Vicentin, Sara Araujo Pereira, Denicar Lina Nascimento Fabris Maeda, Rúbens Prince dos Santos Alves, Robert Andreata-Santos, Francielle Tramontini Gomes de Sousa, Marcio Massao Yamamoto, Maria Fernanda Castro-Amarante, Marianna Teixeira de Pinho Favaro, Camila Malta Romano, Ester Cerdeira Sabino, Silvia Beatriz Boscardin, Luís Carlos de Souza Ferreira |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/8/4/565 |
Similar Items
-
Intradermal Allergen Immunotherapy for Allergic Rhinitis: Current Evidence
by: Kawita Atipas, et al.
Published: (2022-08-01) -
Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies
by: Christian H. K. Lehmann, et al.
Published: (2016-03-01) -
Comparison of Absorbable and Nonabsorbable Sutures for Intradermal Skin Closure in Dogs
by: Dimitrios B. Balomenos, et al.
Published: (2023-02-01) -
Immunogenicity, safety and tolerability of intradermal influenza vaccines
by: Ivan F. N. Hung, et al.
Published: (2018-03-01) -
Canine experimental infection: intradermal inoculation of Leishmania infantum promastigotes
by: Gabriela M Santos-Gomes, et al.
Published: (2000-04-01)